Arlene Siefker-Radtke, MD, shares key takeaways from her experience at ESMO 2022, focused on advanced or metastatic urothelial cancer.
Post Conference Perspectives
Dr Millie Das, MD discusses updates from the 2022 World Conference on Lung Cancer regarding non-small cell lung cancer (NSCLC).
Expert insight on multiple myeloma management updates from the ASH 2021 annual meeting.
Robert Toto, MD, reviews key takeaways from the 2021 Academy of Managed Care Pharmacy meeting regarding healthcare resource utilization for patients with chronic kidney disease (CKD).
Petros Grivas, MD, PhD, reviews emerging data from the 2021 ASCO GU Virtual Symposium on the role of immune checkpoint inhibitors for the treatment of advanced and metastatic urothelial carcinoma.
An expert in the field of multiple myeloma discusses key data releases from ASH 2020.
An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.
Infectious disease expert discusses key data releases from ID Week 2020 within the field of HIV care.
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5
